Updated
Interactive urgent-help guidance – no risk score
GHB and GBL concerns
Choose the situation that is relevant to read direct-help guidance. Do not wait to complete questions. This is a help navigator, not a clinical safety assessment, diagnostic test or prediction of future harm.
Someone is difficult to wake or is breathing abnormally
Contact local emergency services immediately and follow the dispatcher's instructions.
Agitation, confusion or hallucinations occur after reducing use
Seek emergency medical assessment. Do not attempt to manage severe withdrawal through an online tool.
I use frequently and want to stop or reduce
Speak to an appropriately qualified medical service before making changes. Withdrawal can need supervised care; an online checklist cannot select the setting.
These choices do not establish whether someone is safe or whether it is safe to wait. Help does not depend on completing anything. No answers, contact details or alerts are sent by this navigator; contact the appropriate service directly.
Background professional guidance. This source does not endorse VAYEMA or validate this help navigator.
Urgent assessment comes before a self-test
GHB-related withdrawal can develop and worsen quickly, so a person should not wait to complete a questionnaire before contacting medical care. An online tool cannot observe breathing, examine someone, monitor confusion or respond to a seizure. The NHS advice on GHB/GBL directs people with suspected withdrawal to urgent emergency-department assessment.
Tell the receiving service that GHB or GBL may be involved and describe current symptoms. You do not need certainty about the product or the diagnosis before asking for help. If you are supporting someone who cannot respond normally or breathe normally, call emergency services and follow their instructions. The absence of symptoms in a short written description cannot establish safety. This worksheet is not monitored and generates no alert, regardless of what is entered.
What the clinician needs to know about recent use
The clinician may ask about the substance name, pattern of use, approximate timing, recent changes and what happens between uses. Repeated use across the day or night can be important information. The point is to identify medical needs, not obtain a confession. Describe what you know accurately and label estimates or unknown product contents as uncertain rather than trying to provide a reassuring answer.
Amounts and product strengths may be hard to reconstruct. Explain that directly instead of calculating a false precision. A clinician can assess the present situation while deciding what further history is useful. Do not delay urgent care to locate packaging, contact a supplier or rebuild every episode. The NHS Club Drug Clinic resource explains why the pattern and its consequences matter alongside the substance’s name.
Previous withdrawal and overdose can change the plan
Tell the professional about past shaking, hallucinations, confusion, seizures or hospital care associated with reducing or stopping. Also mention loss of consciousness or breathing problems during use. Withdrawal and intoxication have different immediate implications, but both need careful assessment. Previous uncomplicated experiences should not be used to assume that the next episode will be safe or that a familiar self-management plan remains appropriate.
A brief record can identify the approximate date, symptoms and service involved when known. Detailed discharge information may help later, with appropriate permission, but the lack of it should not prevent urgent evaluation. The ACMD harms assessment describes severe withdrawal and the challenges of clinical management. A clinician must interpret your history rather than compare it with an online severity threshold.
Review every relevant medicine and other substance
Include alcohol, opioids, benzodiazepines, stimulants and prescribed or non-prescribed products. Some people use a second substance to sleep, recover or manage anxiety. The assessment needs to understand those patterns together. You should not be asked to select one main problem while leaving out other exposures that could affect breathing, alertness or withdrawal. A medication list is useful when readily available.
Do not independently stop several medicines or add another substance while waiting for advice. The appropriate order and method of treatment requires medical judgment. The CDC information on combinations explains why stimulants and sedatives do not simply cancel each other. Be clear about which medicines are prescribed and which products have uncertain contents; that distinction helps the receiving team without establishing the diagnosis by itself.
Physical examination and tests answer specific questions
A receiving team may assess vital signs, alertness, hydration and other physical concerns, with investigations selected for the presentation. Testing may help clarify complications or another cause of symptoms. A drug screen is not a complete assessment and cannot independently determine dependence, current safety or the appropriate treatment setting. The person’s condition and history remain essential even when a particular substance is not identified by a limited test.
Ask what each proposed investigation is intended to clarify once the immediate situation allows discussion. An extensive testing package is not automatically more useful than targeted examination and clinical monitoring. Equally, avoiding testing should not be treated as a benefit when there is a clear medical reason for it. The assessment should connect findings to decisions and explain which professional is responsible for reviewing and acting on the results.
Mental health and daily functioning belong in the assessment
After urgent needs are addressed, the discussion can include sleep, mood, anxiety, distress, relationships and daily responsibilities. Experiences during intoxication or withdrawal may need reassessment over time rather than being assigned a permanent psychiatric label immediately. You can describe what has changed and which difficulties continue between episodes. A professional should remain open to both substance-related effects and other conditions that may need their own care.
The understanding guide gives background without diagnosing you. Practical examples might include difficulties maintaining routines, missing activities or worrying about memory gaps. What remains manageable also matters. The aim is a realistic picture of needs and strengths, not proving that life has reached a particular level of disruption before you qualify for support.
A confidential conversation can include sexual-health needs
Where relevant, a clinician can ask about substance use during sex, consent, possible infection exposure or experiences that felt unsafe. These questions should have an explained purpose and be asked without assumptions about identity or relationships. You may prefer to discuss sensitive details with a specific professional or ask for private time without a family member present. An initial website inquiry does not need an explicit account.
Some sexual-health or assault-related concerns need prompt local services rather than waiting until ongoing addiction care begins. The NHS GHB/GBL resource sits within a sexual-health service and describes relevant support. Your assessment should not equate a particular lifestyle with a diagnosis. It should identify what help is needed and how to coordinate it appropriately, with clear confidentiality arrangements.
How the care setting is decided
The decision about hospital, specialist withdrawal care or later outpatient treatment depends on symptoms, medical history, other substances and actual service capability. It cannot be made from a worksheet score, ability to pay or preference for a private residence. An initial period of apparent stability does not guarantee that symptoms will remain manageable without medical observation. The professional should explain immediate priorities and any uncertainty.
For planned follow-up, ask what the proposed setting provides and what lies outside its scope. A regular therapy session does not include emergency monitoring. Our GHB and GBL treatment guide distinguishes withdrawal management from continuing recovery work. A referral to another service can be the appropriate outcome of assessment, not a failure to find a package within one organization.
Using preparation notes without creating another barrier
Write only what will help a professional understand the situation. Short, approximate observations are sufficient for preparation; there is no requirement to complete every field. Do not include names or unnecessary details about other people. The tool repeats your own words rather than interpreting them. It has no clinical threshold, diagnostic label or automatic recommendation and is not a substitute for a validated professional assessment.
Answers are not sent to VAYEMA through this worksheet. Any file you deliberately download remains under your control and should be stored privately. Share it only through a channel agreed with the receiving professional. Someone helping with notes should distinguish their observations from your own account. If preparation is distressing, confusing or delaying help, stop and contact the appropriate service directly.
What a useful assessment and handover should provide
You should understand the immediate medical priorities, who is taking responsibility and what happens next. Once acute care is complete, the ongoing plan can explain psychological support, medical follow-up, practical needs and review arrangements. Ask about the cost and purpose of each component. Clear roles matter particularly when a hospital, existing therapist and new outpatient service may all be involved.
VAYEMA’s assessment pathway can discuss a suitable planned role, while care coordination may support agreed handovers and family support may address relatives’ own concerns. These are not emergency services. An urgent situation must go directly to local medical care rather than wait for an inquiry reply, a complete note or another online result.
Frequently asked questions about GHB and GBL assessment
Is this a scored GHB addiction test?
No. It is an original preparation worksheet without a score, diagnostic threshold or probability estimate. It helps organize information for a clinician after urgent needs have been addressed. It cannot diagnose dependence, monitor withdrawal, assess capacity or establish whether it is safe to remain at home.
What should I do if withdrawal may already be starting?
Seek urgent medical assessment directly. Do not wait to finish the worksheet or make an unsupported abrupt change to use. Tell the receiving service that GHB or GBL may be involved. Severe confusion, hallucinations, seizures, unconsciousness or abnormal breathing needs an emergency response, not a routine appointment request.
Do I need to know the exact product strength?
No. Explain what is known and what is uncertain. An accurate statement that strength or contents are unknown is more useful than an invented estimate. The clinician can assess current symptoms and identify further information needed. Do not delay urgent care while trying to establish product details or recover old messages.
Can a negative drug test rule out a problem?
A test only answers questions within its design and timing. It does not replace examination, the history or observation of changing symptoms. The clinician must interpret results with the wider picture. A negative or incomplete screen should not be used as an online safety clearance or a reason to dismiss serious current symptoms.
Can a relative provide information when I struggle to remember?
Their observations may help, particularly during an acute presentation, with appropriate clinical and confidentiality arrangements. They should distinguish what they witnessed from what they infer. They cannot diagnose you through this worksheet or use it to authorize treatment. The responsible professionals should explain participation and information-sharing arrangements.
Will typing an emergency concern notify the team?
No. Worksheet entries are not transmitted or monitored and do not generate alerts. For an urgent concern, contact the relevant medical or emergency service directly. Routine VAYEMA inquiries are also not crisis monitoring. You can seek help without a completed worksheet; its only purpose is optional preparation for an appropriate conversation.
Resources and references
[1] NHS iCaSH: urgent advice for GHB/GBL withdrawal
[2] NHS Club Drug Clinic: GHB and GBL
[3] ACMD: GHB-related harms and clinical-management considerations